James L Gulley (James Gulley)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 84

Top Venues

Journal for immunotherapy of cancer

The oncologist

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

National Cancer Institute

Loma Linda University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Jul 01 1998

United States

Chief, Genitourinary Malignancies Branch :: Center for Cancer Research

Education History

Loma Linda University

United States

PHD :: Microbiology

Publications

Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Arun Rajan, Houssein Abdul Sater, Osama Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L Marté, Yo-Ting Tsai, Renee N Donahue, Elizabeth Lamping, Shania Bailey, Andrew Weisman, Beatriz Walter-Rodriguez, Rena Ito, Yulia Vugmeyster, Masashi Sato, Andreas Machl, Jeffrey Schlom, James L Gulley
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 12 (3) (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Danh-Tai Hoang, Gal Dinstag, Eldad David Shulman, Leandro C Hermida, Doreen S Ben-Zvi, Efrat Elis, Katherine Caley, Stephen-John Sammut, Sanju Sinha, Neelam Sinha, Christopher H Dampier, Chani Stossel, Tejas Patil, Arun Rajan, Wiem Lassoued, Julius Strauss, Shania Bailey, Clint T Allen, Jason Mark Redman, Tuvik Beker, Peng Jiang, Talia Golan, Scott Wilkinson, Adam G Sowalsky, Sharon R Pine, Carlos Caldas, James L Gulley, Kenneth D Aldape, Ranit Aharonov, Eric A Stone, Eytan Ruppin
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. Nature cancer (2024)
Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for immunotherapy of cancer 12 (6) (2024)
Arun Rajan, Houssein Abdul Sater, Osama Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L Marté, Yo-Ting Tsai, Renee N Donahue, Elizabeth Lamping, Shania Bailey, Andrew Weisman, Beatriz Walter-Rodriguez, Rena Ito, Yulia Vugmeyster, Masashi Sato, Andreas Machl, Jeffrey Schlom, James L Gulley
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 12 (3) (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Danh-Tai Hoang, Gal Dinstag, Eldad David Shulman, Leandro C Hermida, Doreen S Ben-Zvi, Efrat Elis, Katherine Caley, Stephen-John Sammut, Sanju Sinha, Neelam Sinha, Christopher H Dampier, Chani Stossel, Tejas Patil, Arun Rajan, Wiem Lassoued, Julius Strauss, Shania Bailey, Clint T Allen, Jason Mark Redman, Tuvik Beker, Peng Jiang, Talia Golan, Scott Wilkinson, Adam G Sowalsky, Sharon R Pine, Carlos Caldas, James L Gulley, Kenneth D Aldape, Ranit Aharonov, Eric A Stone, Eytan Ruppin
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. Nature cancer (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Elisabetta Xue, Dara Bracken-Clarke, Giovanni Maria Iannantuono, Hyoyoung Choo-Wosoba, James L Gulley, Charalampos S Floudas
Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard. Journal of medical Internet research 26 (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for immunotherapy of cancer 12 (7) (2024)
Elisabetta Xue, Dara Bracken-Clarke, Giovanni Maria Iannantuono, Hyoyoung Choo-Wosoba, James L Gulley, Charalampos S Floudas
Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard. Journal of medical Internet research 26 (2024)
Arun Rajan, Houssein Abdul Sater, Osama Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L Marté, Yo-Ting Tsai, Renee N Donahue, Elizabeth Lamping, Shania Bailey, Andrew Weisman, Beatriz Walter-Rodriguez, Rena Ito, Yulia Vugmeyster, Masashi Sato, Andreas Machl, Jeffrey Schlom, James L Gulley
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 12 (3) (2024)
Elisabetta Xue, Dara Bracken-Clarke, Giovanni Maria Iannantuono, Hyoyoung Choo-Wosoba, James L Gulley, Charalampos S Floudas
Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard. Journal of medical Internet research 26 (2024)
Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for immunotherapy of cancer 12 (6) (2024)
Elisabetta Xue, Dara Bracken-Clarke, Giovanni Maria Iannantuono, Hyoyoung Choo-Wosoba, James L Gulley, Charalampos S Floudas
Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard. Journal of medical Internet research 26 (2024)
Arun Rajan, Houssein Abdul Sater, Osama Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L Marté, Yo-Ting Tsai, Renee N Donahue, Elizabeth Lamping, Shania Bailey, Andrew Weisman, Beatriz Walter-Rodriguez, Rena Ito, Yulia Vugmeyster, Masashi Sato, Andreas Machl, Jeffrey Schlom, James L Gulley
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 12 (3) (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for immunotherapy of cancer 12 (6) (2024)
Mary Helen Barcellos-Hoff, James L Gulley
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fabrice Barlesi, Nicolas Isambert, Enriqueta Felip, Byoung Chul Cho, Dae Ho Lee, Julio Peguero, Guy Jerusalem, Nicolas Penel, Esma Saada-Bouzid, Pilar Garrido, Christoph Helwig, George Locke, Laureen S Ojalvo, James L Gulley
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors. The oncologist 28 (3) (2023)
Julius Strauss, Jean-Laurent Deville, Mario Sznol, Alain Ravaud, Marco Maruzzo, Russell K Pachynski, Theodore S Gourdin, Michele Maio, Luc Dirix, Jeffrey Schlom, Renee N Donahue, Yo-Ting Tsai, XiaoZhe Wang, Yulia Vugmeyster, Frank Beier, Joerg Seebeck, Andreas Schroeder, Sarah Chennoufi, James L Gulley
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma. Journal for immunotherapy of cancer 11 (5) (2023)
Eytan Ruppin, Danh-Tai Hoang, Gal Dinstag, Leandro Hermida, Doreen S Ben-Zvi, Efrat Elis, Katherine Caley, Stephen-John Sammut, Sanju Sinha, Neelam Sinha, Christopher H Dampier, Chani Stossel, Tejas Patil, Arun Rajan, Wiem Lassoued, Julius Strauss, Shania Bailey, Clint T Allen, Jason Redman, Tuvik Beker, Peng Jiang, Talia Golan, Scott Wilkinson, Adam G Sowalsky, Sharon R Pine, Carlos Caldas, James L Gulley, Kenneth D Aldape, Ranit Aharonov, Eric Stone
Prediction of cancer treatment response from histopathology images through imputed transcriptomics. Research square (2023)
Michael B Atkins, Paolo Antonio Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet M Kluger, Ryan J Sullivan, Hussein A Tawbi
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Journal for immunotherapy of cancer 11 (3) (2023)
Scott M Norberg, Ke Bai, Cem Sievers, Yvette Robbins, Jay Friedman, Xinping Yang, Meg Kenyon, Elizabeth Ward, Jeffrey Schlom, James L Gulley, Amy Lankford, Roshanak Semnani, Helen Sabzevari, Douglas E Brough, Clint T Allen
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis. Science translational medicine 15 (719) (2023)
Ryan Chang, James L Gulley, Lawrence Fong
Vaccinating against cancer: getting to prime time. Journal for immunotherapy of cancer 11 (6) (2023)
Thomas A Odeny, Kathryn Lurain, Julius Strauss, Steven P Fling, Elad Sharon, Anna Wright, Javier Martinez-Picado, Teresa Morán, James L Gulley, Maria Gonzales Cao, Thomas S Uldrick, Robert Yarchoan, Ramya Ramaswami
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer. Journal for immunotherapy of cancer 10 (9) (2023)
Michael B Atkins, Paolo Antonio Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet M Kluger, Ryan J Sullivan, Hussein A Tawbi
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Journal for immunotherapy of cancer 11 (3) (2023)
Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss, Ravi A Madan, Fatima H Karzai, Marijo Bilusic, Jason Mark Redman, Houssein Abdul Sater, Charalampos S Floudas, Nicole J Toney, Renee N Donahue, Caroline Jochems, Jennifer L Marté, Deneise Francis, Sheri McMahon, Elizabeth Lamping, Lisa M Cordes, Jeffrey Schlom, James L Gulley
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors. The oncologist (2023)
Rosa Nguyen, Ekaterina Doubrovina, Charlotte M Mousset, Benjamin Y Jin, Reona Okada, Xiyuan Zhang, Arina Clavel, Jeyshka M Reyes-González, Vadim Dyomin, Louis Diaz, Ling Zhang, Shahroze Abbas, Ming Sun, Chao-Ming Hsieh, Mitchell Ho, Jack F Shern, James L Gulley, Christian S Hinrichs
Cooperative armoring of CAR and TCR T-cells by T cell-restricted IL-15 and IL-21 universally enhances solid tumor efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mary Helen Barcellos-Hoff, James L Gulley
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jonathan Hsu, Renee N Donahue, Madan Katragadda, Jessica Lowry, Wei Huang, Karunya Srinivasan, Gurkan Guntas, Jian Tang, Roya Servattalab, Jacques Moisan, Yo-Ting Tsai, Allart Stoop, Sangeetha Palakurthi, Raj Chopra, Ke Liu, E John Wherry, Zhen Su, James L Gulley, Andrew Bayliffe, Jeffrey Schlom
A T cell receptor β chain-directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity. Science translational medicine 15 (724) (2023)
Marijo Bilusic, Nicole J Toney, Renee N Donahue, Susan Wroblewski, Matthew Zibelman, Pooja Ghatalia, Eric A Ross, Fatima Karzai, Ravi A Madan, William L Dahut, James L Gulley, Jeffrey Schlom, Elizabeth R Plimack, Daniel M Geynisman
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate cancer and prostatic diseases 25 (4) (2022)
Meghali Goswami, Gege Gui, Laura W Dillon, Katherine E Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y Ghannam, Karolyn A Oetjen, Christin B Destefano, Dana M Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Thomas Hughes, Jennifer L Marté, Jaydira Del Rivero, Joanna Klubo-Gwiezdzinksa, James L Gulley, Katherine R Calvo, Catherine Lai, Christopher S Hourigan
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia. Journal for immunotherapy of cancer 10 (1) (2022)
Yo-Ting Tsai, Julius Strauss, Nicole J Toney, Caroline Jochems, David J Venzon, James L Gulley, Jeffrey Schlom, Renee N Donahue
Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa. Journal for immunotherapy of cancer 10 (4) (2022)
Nicholas P Tschernia, Scott M Norberg, James L Gulley
CAR T cells reach clinical milestone in prostate cancer. Nature medicine 28 (4) (2022)
Marijo Bilusic, James L Gulley
Neoadjuvant Immunotherapy: An Evolving Paradigm Shift? Journal of the National Cancer Institute 113 (7) (2022)
John S Davies, Farrah Karimipour, Ling Zhang, Nisha Nagarsheth, Scott M Norberg, Carylinda Serna, Julius Strauss, Shinheng Chiou, James L Gulley, Christian S Hinrichs
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors. Journal for immunotherapy of cancer 10 (7) (2022)
Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Anaida Widell, Irene Ekwede, Jomy George, Richard Ambinder, Martin Cheever, James L Gulley, Priscila H Goncalves, Hao-Wei Wang, Thomas S Uldrick, Robert Yarchoan
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma. Journal for immunotherapy of cancer 9 (2) (2022)
Juliane Manitz, Sandra P D' Angelo, Andrea B Apolo, S Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L Gulley
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival. Journal for immunotherapy of cancer 10 (2) (2022)
Arun Rajan, Jhanelle E Gray, Siddhartha Devarakonda, Ruemu Birhiray, Borys Korchin, Erika Menius, Renee N Donahue, Jeffrey Schlom, James L Gulley
Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer. International journal of cancer (2022)
Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, David R Spigel, Howard Safran, Matthew H Taylor, Jaafar Bennouna, Deborah J Wong, Karen Kelly, Claire F Verschraegen, Marcis Bajars, Juliane Manitz, Mary Ruisi, James L Gulley
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor. Future oncology (London, England) 18 (11) (2022)
Michael B Atkins, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Michael R Bishop, Daniel C Chen, Madhav Dhodapkar, Leisha A Emens, Marc S Ernstoff, Matthew J Ferris, Tim F Greten, James L Gulley, Roy S Herbst, Rachel W Humphrey, James Larkin, Kim A Margolin, Luca Mazzarella, Suresh S Ramalingam, Meredith M Regan, Brian I Rini, Mario Sznol
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). Journal for immunotherapy of cancer 10 (9) (2022)
Pedro J Romero, James L Gulley, Patrick Hwu, Mary Dean, Samuel Million-Weaver
Celebrating a decade of the Journal for ImmunoTherapy of Cancer . Journal for immunotherapy of cancer 10 (5) (2022)
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, Lisa M Cordes, Cindy H Chau, Cody J Peer, Susan Wroblewski, Alwin D R Huitema, Jan H M Schellens, James L Gulley, William L Dahut, William Douglas Figg, Ravi A Madan
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide. The oncologist 27 (9) (2022)
Fabrice Barlesi, Nicolas Isambert, Enriqueta Felip, Byoung Chul Cho, Dae Ho Lee, Julio Peguero, Guy Jerusalem, Nicolas Penel, Esma Saada-Bouzid, Pilar Garrido, Christoph Helwig, George Locke, Laureen S Ojalvo, James L Gulley
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors. The oncologist (2022)
Peter Joseph DeMaria, Katherine Lee-Wisdom, Renee N Donahue, Ravi A Madan, Fatima Karzai, Angie Schwab, Claudia Palena, Caroline Jochems, Charalampos S Floudas, Julius Strauss, Jennifer L Marté, Jason Mark Redman, Eva Dombi, Brigitte Widemann, Borys Korchin, Tatiana Adams, Cesar Pico-Navarro, Christopher Heery, Jeffrey Schlom, James L Gulley, Marijo Bilusic
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer. Journal for immunotherapy of cancer 9 (9) (2022)
Jason Mark Redman, Yo-Ting Tsai, Benjamin A Weinberg, Renee N Donahue, Shruti U Gandhy, Margaret E Gatti-Mays, Houssein Abdul Sater, Marijo Bilusic, Lisa M Cordes, Seth M Steinberg, Jennifer L Marte, Caroline Jochems, Sunnie S Kim, John L Marshall, Sheri McMahon, Erica Redmond, Jeffrey Schlom, James L Gulley, Julius Strauss
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer. The oncologist 27 (3) (2022)
Cristina Mullenix, Madison Ballman, Haobin Chen, Shannon Swift, Meredith J McAdams, Yo-Ting Tsai, Renee N Donahue, Trina Poretta, Sarthak Gupta, Patrick J Loehrer, Jeffrey Schlom, James L Gulley, Arun Rajan
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors. The oncologist 27 (4) (2022)
Yvette Robbins, Jay Friedman, Paul E Clavijo, Cem Sievers, Ke Bai, Renee N Donahue, Jeffrey Schlom, Andrew Sinkoe, Christian S Hinrichs, Clint T Allen, Houssein Abdul Sater, James L Gulley, Scott M Norberg
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis. Journal for immunotherapy of cancer 9 (8) (2022)
Hannah Reimann, Andrew Nguyen, J Zachary Sanborn, Charles J Vaske, Stephen C Benz, Kayvan Niazi, Shahrooz Rabizadeh, Patricia Spilman, Andreas Mackensen, Matthias Ruebner, Alexander Hein, Matthias W Beckmann, Edith D van der Meijden, Judith Bausenwein, Sascha Kretschmann, Marieke Griffioen, Jeffrey Schlom, James L Gulley, Karin L Lee, Duane H Hamilton, Patrick Soon-Shiong, Peter A Fasching, Anita N Kremer
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy. Journal for immunotherapy of cancer 9 (6) (2022)
Sofia R Gameiro, Julius Strauss, James L Gulley, Jeffrey Schlom
Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status. Experimental biology and medicine (Maywood, N.J.) 247 (13) (2022)
Margaret E Gatti-Mays, James L Gulley
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis. Journal for immunotherapy of cancer 9 (2) (2022)
Nicholas P Tschernia, James L Gulley
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (2) (2022)
Claire F Verschraegen, Guy Jerusalem, Edward F McClay, Nicholas Iannotti, Charles H Redfern, Jaafar Bennouna, Franklin L Chen, Karen Kelly, Janice Mehnert, John C Morris, Matthew Taylor, David Spigel, Ding Wang, Hans Juergen Grote, Dongli Zhou, Neru Munshi, Marcis Bajars, James L Gulley
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Journal for immunotherapy of cancer 8 (2) (2021)
Samira Masoudi, Sherif Mehralivand, Stephanie A Harmon, Nathan Lay, Liza Lindenberg, Esther Mena, Peter A Pinto, Deborah E Citrin, James L Gulley, Bradford J Wood, William L Dahut, Ravi A Madan, And Ulas Bagci, Peter C Black, Ismail Baris Turkbey
Deep Learning Based Staging of Bone Lesions From Computed Tomography Scans. IEEE access : practical innovations, open solutions 9 (2021)
Marijo Bilusic, Sheri McMahon, Ravi A Madan, Fatima Karzai, Yo-Ting Tsai, Renee N Donahue, Claudia Palena, Caroline Jochems, Jennifer L Marté, Charalampos S Floudas, Julius Strauss, Jason Redman, Houssein Abdul Sater, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, James L Gulley
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer 9 (3) (2021)
Karen Kelly, Juliane Manitz, Manish R Patel, Sandra P D' Angelo, Andrea B Apolo, Arun Rajan, Vijay Kasturi, Isabell Speit, Marcis Bajars, John Warth, James L Gulley
Efficacy and immune-related adverse event associations in avelumab-treated patients. Journal for immunotherapy of cancer 8 (2) (2021)
Ravi A Madan, Fatima Karzai, Renee N Donahue, Munjid Al-Harthy, Marijo Bilusic, Inger I Rosner, Harpreet Singh, Philip M Arlen, Marc R Theoret, Jennifer L Marté, Lisa M Cordes, Anna Couvillon, Amy Hankin, Moniquea Williams, Helen Owens, Sarah E Lochrin, Cindy H Chau, Seth Steinberg, William Douglas Figg, William Dahut, Jeffrey Schlom, James L Gulley
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer. Journal for immunotherapy of cancer 9 (3) (2021)
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward McClay, Jason M Redman, Houssein Abdul Sater, Renee N Donahue, Caroline Jochems, Elizabeth Lamping, Andrea Burmeister, Jennifer L Marté, Lisa M Cordes, Marijo Bilusic, Fatima Karzai, Laureen S Ojalvo, Genevieve Jehl, P Alexander Rolfe, Christian S Hinrichs, Ravi A Madan, Jeffrey Schlom, James L Gulley
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies. Journal for immunotherapy of cancer 8 (2) (2021)
Houssein Abdul Sater, Jennifer L Marté, Renee N Donahue, Beatriz Walter-Rodriguez, Christopher R Heery, Seth M Steinberg, Lisa M Cordes, Guinevere Chun, Fatima Karzai, Marijo Bilusic, Stephanie A Harmon, Ismail Baris Turkbey, Peter L Choyke, Jeffrey Schlom, William L Dahut, Ravi A Madan, Peter A Pinto, James L Gulley
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer. Journal for immunotherapy of cancer 8 (1) (2021)
Hanne Lind, Sofia R Gameiro, Caroline Jochems, Renee N Donahue, Julius Strauss, James L Gulley, Claudia Palena, Jeffrey Schlom
Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances. Journal for immunotherapy of cancer 8 (1) (2021)
Aung Naing, Joud Hajjar, James L Gulley, Michael B Atkins, Gennaro Ciliberto, Funda Meric-Bernstam, Patrick Hwu
Strategies for improving the management of immune-related adverse events. Journal for immunotherapy of cancer 8 (2) (2021)
Byoung Chul Cho, Amaury Daste, Alain Ravaud, Sébastien Salas, Nicolas Isambert, Edward McClay, Ahmad Awada, Christian Borel, Laureen S Ojalvo, Christoph Helwig, P Alexander Rolfe, James L Gulley, Nicolas Penel
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort. Journal for immunotherapy of cancer 8 (2) (2021)
James L Gulley, Jeffrey Schlom, Mary Helen Barcellos-Hoff, Xiao-Jing Wang, Joan Seoane, Francois Audhuy, Yan Lan, Isabelle Dussault, Aristidis Moustakas
Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment. Molecular oncology (2021)
Peter Joseph DeMaria, Marijo Bilusic, Deric M Park, Christopher R Heery, Renee N Donahue, Ravi A Madan, Mohammad Hadi Bagheri, Julius Strauss, Victoria Shen, Jennifer L Marté, Seth M Steinberg, Jeffrey Schlom, Mark R Gilbert, James L Gulley
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma. The oncologist 26 (5) (2021)
Harriet M Kluger, Hussein A Tawbi, Maria L Ascierto, Michaela Bowden, Margaret K Callahan, Edward Cha, Helen X Chen, Charles G Drake, David M Feltquate, Robert L Ferris, James L Gulley, Shilpa Gupta, Rachel W Humphrey, Theresa M LaVallee, Dung T Le, Vanessa M Hubbard-Lucey, Vassiliki A Papadimitrakopoulou, Michael A Postow, Eric H Rubin, Elad Sharon, Janis M Taube, Suzanne L Topalian, Roberta Zappasodi, Mario Sznol, Ryan J Sullivan
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce. Journal for immunotherapy of cancer 8 (1) (2021)
Andrea B Apolo, John A Ellerton, Jeffrey R Infante, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Luc Dirix, Keun-Wook Lee, Matthew H Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Juliane Manitz, Gregory Pennock, Mary Ruisi, James L Gulley, Manish R Patel
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. Journal for immunotherapy of cancer 8 (2) (2021)
Renee N Donahue, Jennifer L Marté, Meghali Goswami, Nicole J Toney, Yo-Ting Tsai, James L Gulley, Jeffrey Schlom
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic. Journal for immunotherapy of cancer 9 (3) (2021)
Scott Wilkinson, Stephanie A Harmon, Nicholas T Terrigino, Fatima Karzai, Peter A Pinto, Ravi A Madan, David J VanderWeele, Ross Lake, Rayann Atway, John R Bright, Nicole V Carrabba, Shana Y Trostel, Rosina T Lis, Guinevere Chun, James L Gulley, Maria J Merino, Peter L Choyke, Huihui Ye, William L Dahut, Baris Turkbey, Adam G Sowalsky
A case report of multiple primary prostate tumors with differential drug sensitivity. Nature communications 11 (1) (2020)
Andrea B Apolo, Rosa Nadal Rios, Daniel M Girardi, Scot A Niglio, Lisa Ley, Lisa M Cordes, Seth M Steinberg, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Marissa Mallek, Nicole N Davarpanah, Rene Costello, Jane B Trepel, Min-Jung Lee, Maria J Merino, Mohammad Hadi Bagheri, Paul Monk, William D Figg, James L Gulley, Piyush K Agarwal, Vladimir Valera, Heather J Chalfin, Jennifer C Jones, Howard Streicher, John J Wright, Yangmin M Ning, Howard L Parnes, William L Dahut, Donald P Bottaro, Primo N Lara, Biren Saraiya, Sumanta Kumar Pal, Mark N Stein, Amir Mortazavi
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (31) (2020)
Ravi A Madan, James L Gulley
Pembrolizumab: patient selection or immune intensification? Nature reviews. Urology 15 (10) (2020)
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, Ravi A Madan, Joanna H Shih, Maria J Merino, Stephanie A Harmon, David J VanderWeele, Lisa M Cordes, Nicole V Carrabba, John R Bright, Nicholas T Terrigino, Guinevere Chun, Marijo Bilusic, Anna Couvillon, Amy Hankin, Monique N Williams, Rosina T Lis, Huihui Ye, Peter L Choyke, James L Gulley, Adam G Sowalsky, Baris Turkbey, Peter A Pinto, William L Dahut
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Yvette Robbins, Sarah Greene, Jay Friedman, Paul E Clavijo, Carter Van Waes, Kellsye P Fabian, Michelle R Padget, Houssein Abdul Sater, John H Lee, Patrick Soon-Shiong, James L Gulley, Jeffrey Schlom, James W Hodge, Clint T Allen
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife 9 (2020)
Jennifer L Marté, Nicole J Toney, Lisa M Cordes, Jeffrey Schlom, Renee N Donahue, James L Gulley
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management. Journal for immunotherapy of cancer 8 (2) (2020)
Heather J Chalfin, Tiziano Pramparo, Amir Mortazavi, Scot A Niglio, Joseph D Schonhoft, Adam Jendrisak, Yen-Lin Chu, Robin Richardson, Rachel Krupa, Amanda K L Anderson, Yipeng Wang, Ryan Dittamore, Sumanta K Pal, Primo N Lara, Mark N Stein, David I Quinn, Seth M Steinberg, Lisa M Cordes, Lisa Ley, Marissa Mallek, Olena Sierra Ortiz, Rene Costello, Jacqueline Cadena, Carlos Diaz, James L Gulley, William L Dahut, Howard Streicher, John J Wright, Jane B Trepel, Donald P Bottaro, Andrea B Apolo
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Paolo Antonio Ascierto, Bernard A Fox, Walter J Urba, Ana Carrizosa Anderson, Michael B Atkins, Ernest C Borden, Julie R Brahmer, Lisa H Butterfield, Alessandra Cesano, Daniel C Chen, Tanja D de Gruijl, Robert O Dillman, Charles G Drake, Leisha A Emens, Thomas F Gajewski, James L Gulley, F Jr Stephen Hodi, Patrick Hwu, David Kaufman, Howard L Kaufman, Michael T Lotze, Douglas G McNeel, Kim M Margolin, Francesco M Marincola, Michael J Mastrangelo, Marcela V Maus, David R Parkinson, Pedro J Romero, Paul M Sondel, Stefani Spranger, Mario Sznol, George J Weiner, Jon M Wigginton, Jeffrey S Weber
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. Journal for immunotherapy of cancer 8 (1) (2020)
Michael J Morris, Eva Corey, Theresa A Guise, James L Gulley, William Kevin Kelly, David I Quinn, Arne Scholz, George Sgouros
Radium-223 mechanism of action: implications for use in treatment combinations. Nature reviews. Urology 16 (12) (2019)
Himisha Beltran, Andrew Hruszkewycz, Howard I Scher, Jeffrey Hildesheim, Jennifer Isaacs, Evan Y Yu, Kathleen Kelly, Daniel Lin, Adam Dicker, Julia Arnold, Toby Hecht, Max Wicha, Rosalie Sears, David Rowley, Richard M White, James L Gulley, John Lee, Maria Diaz Meco, Eric J Small, Michael M Shen, Karen Knudsen, David W Goodrich, Tamara Lotan, Amina Zoubeidi, Charles M Rudin, Massimo Loda, Timothy Thompson, Mark A Rubin, Abdul Tawab-Amiri, William Dahut, Peter S Nelson
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (23) (2019)
Daniella E Portal, Robert E Weiss, Malgorzata Wojtowicz, Amal Mansour, Claude Monken, Janice M Mehnert, Joseph A Aisner, Michael Kane, Jennifer Nishioka, Seena Aisner, Stephen Peters, Mark N Stein, Isaac Y Kim, Tina M Mayer, Weichung Shih, James L Gulley, Howard Streicher, Eric A Singer, Edmund C Lattime
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. Cancer gene therapy 27 (6) (2019)
Marijo Bilusic, Christopher R Heery, Julie M Collins, Renee N Donahue, Claudia Palena, Ravi A Madan, Fatima Karzai, Jennifer L Marté, Julius Strauss, Margaret E Gatti-Mays, Jeffrey Schlom, James L Gulley
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. Journal for immunotherapy of cancer 7 (1) (2019)
Julie M Collins, James L Gulley
Product review: avelumab, an anti-PD-L1 antibody. Human vaccines & immunotherapeutics 15 (4) (2018)

James L Gulley.css-eqlu8i{font-size:small;padding-left:4px;} (James Gulley)

Publication Activity (10 Years)

Top Topics

Top Venues

James L Gulley (James Gulley)